S&P 500   4,431.85 (+2.43%)
DOW   34,725.47 (+1.65%)
QQQ   351.80 (+3.14%)
AAPL   170.33 (+6.98%)
MSFT   308.26 (+2.81%)
FB   301.71 (+2.40%)
GOOGL   2,667.02 (+3.37%)
AMZN   2,879.56 (+3.11%)
TSLA   846.35 (+2.08%)
NVDA   228.40 (+4.08%)
BABA   115.23 (+3.08%)
NIO   20.90 (-0.99%)
AMD   105.24 (+2.57%)
CGC   7.27 (+6.13%)
MU   79.27 (+0.70%)
GE   92.10 (+2.45%)
T   25.21 (+4.52%)
F   19.54 (-0.05%)
DIS   138.63 (+2.37%)
AMC   15.06 (+3.72%)
PFE   54.33 (+1.80%)
ACB   3.91 (+3.17%)
BA   190.57 (+0.43%)
S&P 500   4,431.85 (+2.43%)
DOW   34,725.47 (+1.65%)
QQQ   351.80 (+3.14%)
AAPL   170.33 (+6.98%)
MSFT   308.26 (+2.81%)
FB   301.71 (+2.40%)
GOOGL   2,667.02 (+3.37%)
AMZN   2,879.56 (+3.11%)
TSLA   846.35 (+2.08%)
NVDA   228.40 (+4.08%)
BABA   115.23 (+3.08%)
NIO   20.90 (-0.99%)
AMD   105.24 (+2.57%)
CGC   7.27 (+6.13%)
MU   79.27 (+0.70%)
GE   92.10 (+2.45%)
T   25.21 (+4.52%)
F   19.54 (-0.05%)
DIS   138.63 (+2.37%)
AMC   15.06 (+3.72%)
PFE   54.33 (+1.80%)
ACB   3.91 (+3.17%)
BA   190.57 (+0.43%)
S&P 500   4,431.85 (+2.43%)
DOW   34,725.47 (+1.65%)
QQQ   351.80 (+3.14%)
AAPL   170.33 (+6.98%)
MSFT   308.26 (+2.81%)
FB   301.71 (+2.40%)
GOOGL   2,667.02 (+3.37%)
AMZN   2,879.56 (+3.11%)
TSLA   846.35 (+2.08%)
NVDA   228.40 (+4.08%)
BABA   115.23 (+3.08%)
NIO   20.90 (-0.99%)
AMD   105.24 (+2.57%)
CGC   7.27 (+6.13%)
MU   79.27 (+0.70%)
GE   92.10 (+2.45%)
T   25.21 (+4.52%)
F   19.54 (-0.05%)
DIS   138.63 (+2.37%)
AMC   15.06 (+3.72%)
PFE   54.33 (+1.80%)
ACB   3.91 (+3.17%)
BA   190.57 (+0.43%)
S&P 500   4,431.85 (+2.43%)
DOW   34,725.47 (+1.65%)
QQQ   351.80 (+3.14%)
AAPL   170.33 (+6.98%)
MSFT   308.26 (+2.81%)
FB   301.71 (+2.40%)
GOOGL   2,667.02 (+3.37%)
AMZN   2,879.56 (+3.11%)
TSLA   846.35 (+2.08%)
NVDA   228.40 (+4.08%)
BABA   115.23 (+3.08%)
NIO   20.90 (-0.99%)
AMD   105.24 (+2.57%)
CGC   7.27 (+6.13%)
MU   79.27 (+0.70%)
GE   92.10 (+2.45%)
T   25.21 (+4.52%)
F   19.54 (-0.05%)
DIS   138.63 (+2.37%)
AMC   15.06 (+3.72%)
PFE   54.33 (+1.80%)
ACB   3.91 (+3.17%)
BA   190.57 (+0.43%)
NASDAQ:LMAT

LeMaitre Vascular Earnings Date, Estimates, & History

$41.01
+0.53 (+1.31%)
(As of 01/28/2022 12:00 AM ET)
Add
Compare
Today's Range
$39.48
▼
$41.19
50-Day Range
$40.48
▼
$51.86
52-Week Range
$39.48
▼
$64.50
Volume
124,884 shs
Average Volume
77,383 shs
Market Capitalization
$895.58 million
P/E Ratio
31.07
Dividend Yield
1.09%
Beta
1.31

Earnings Summary

Upcoming
Earnings Date
Feb. 24
Estimated

Actual EPS
(Oct. 28)
$0.30
Missed By -$0.03

Consensus EPS
(Oct. 28)
$0.33

Last Year's Q4 EPS
(10/29/2020)
$0.37

Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

LeMaitre Vascular Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LeMaitre Vascular Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

LeMaitre Vascular (NASDAQ:LMAT) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20222$0.30$0.35$0.33 
Q2 20222$0.38$0.41$0.40 
Q3 20222$0.34$0.38$0.36 
Q4 20222$0.37$0.37$0.37 
FY 20228$1.39$1.51$1.45

LMAT Earnings Information

LeMaitre Vascular last posted its earnings data on October 28th, 2021. The medical instruments supplier reported $0.30 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.33 by $0.03. The firm earned $38.37 million during the quarter, compared to analyst estimates of $39.05 million. Its quarterly revenue was up 5.4% on a year-over-year basis. LeMaitre Vascular has generated $1.32 earnings per share over the last year ($1.32 diluted earnings per share) and currently has a price-to-earnings ratio of 31.1. Earnings for LeMaitre Vascular are expected to grow by 11.63% in the coming year, from $1.29 to $1.44 per share. LeMaitre Vascular has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 24th, 2022 based off prior year's report dates.

LeMaitre Vascular (NASDAQ:LMAT) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
2/24/2022
(Estimated)		        
10/28/20219/30/2021$0.33$0.30($0.03)$0.30$39.05 million$38.37 million    
7/29/20216/30/2021$0.34$0.40+$0.06$0.40$40.70 million$40.67 million    
4/29/20213/31/2021$0.28$0.28$0.28$35.55 million$35.88 million  
2/25/202112/31/2020$0.31$0.34+$0.03$0.34$35.87 million$37.55 million  
10/29/20209/30/2020$0.19$0.37+$0.18$0.37$31.62 million$36.42 million  
7/23/20206/30/2020$0.01$0.17+$0.16$0.17$15.58 million$24.85 million  
4/30/2020Q1 2020$0.16$0.16$0.16$30.50 million$30.55 million  
2/6/2020Q4 2019$0.23$0.23$0.23$30.44 million$30.20 million  
10/23/2019Q3$0.21$0.25+$0.04$0.25$28.15 million$29.10 million  
7/24/2019Q2$0.21$0.23+$0.02$0.23$28.90 million$29.48 million  
5/1/20193/31/2019$0.19$0.17($0.02)$0.17$27.94 million$28.48 million
2/19/201912/31/2018$0.24$0.24$0.18$26.06 million$28.39 million  
10/5/2018Q3 2018$0.2070$0.2090+$0.0020$0.21$26.06 million$24.17 million
7/26/2018Q2 2018$0.42$0.21($0.21)$0.43$27.09 million$27.02 million  
4/25/2018Q1 2018$0.21$0.19($0.02)$0.19$26.42 million$25.99 million
2/21/2018Q4 2017$0.20$0.21+$0.01$0.21$26.23 million$26.15 million  
10/26/2017Q3 2017$0.20$0.25+$0.05$0.25$25.49 million$24.80 million
7/27/2017Q2 2017$0.17$0.23+$0.06$0.23$25.42 million$25.80 million
5/4/2017Q1 2017$0.1310$0.16+$0.0290$0.16$23.48 million$24.10 million
4/26/2017Q1 2017$0.13$0.16+$0.03$0.16$23.50 million$24.14 million
2/21/2017Q4 2016$0.15$0.13($0.02)$0.13$23.70 million$23.30 million  
10/26/2016Q3$0.15$0.17+$0.02$0.17$22.20 million$19.00 million  
7/27/2016Q2$0.11$0.14+$0.03$0.14$21.59 million$22.40 million  
5/2/2016Q1$0.10$0.11+$0.01$0.11$20.22 million$20.26 million  
2/24/2016Q415$0.09$0.13+$0.04$0.13$20.10 million$20.50 million  
10/27/2015Q3$0.0780$0.11+$0.0320$0.11$18.78 million$19.03 million  
7/28/2015Q2$0.07$0.10+$0.03$0.10$18.90 million$19.90 million  
4/28/2015Q115$0.05$0.08+$0.03$0.08$17.76 million$18.90 million  
2/25/2015Q314$0.07$0.11+$0.04$0.11$18.90 million$18.70 million  
10/28/2014Q3$0.06$0.05($0.01)$0.05$17.09 million$17.50 million  
7/29/2014Q2 2014$0.05$0.09+$0.04$0.10$17.57 million$18.16 million
4/29/2014Q1 2014$0.02$0.02$0.05$16.99 million$16.75 million
2/25/2014Q4 2013$0.06$0.05($0.01)$0.05$16.45 million$17.92 million  
10/29/2013Q3 2013$0.05$0.05$0.05$15.22 million$15.30 million  
7/30/2013Q2 2013$0.04$0.06+$0.02$0.06$15.42 million$15.95 million
4/30/2013Q1 2013($0.01)$0.05+$0.06$0.05$15.00 million$15.38 million
2/26/2013Q4 2012$0.06$0.03($0.03)$0.02
10/30/2012Q3 2012$0.04$0.04$0.04
7/31/2012Q2 2012$0.04$0.05+$0.01$0.05
5/2/2012Q1 2012$0.04$0.02($0.02)$0.02
2/27/2012Q4 2011$0.06$0.03($0.03)$0.04
10/27/2011Q3 2011$0.08$0.06($0.02)$0.04
7/28/2011Q2 2011$0.09$0.06($0.03)$0.09
4/28/2011Q1 2011$0.06$0.05($0.01)$0.10
2/28/2011Q4 2010$0.25+$0.25$0.37
10/28/2010Q3 2010$0.08$0.09+$0.01$0.09
7/28/2010Q2 2010$0.06$0.09+$0.03$0.09
4/29/2010Q1 2010$0.05$0.06+$0.01$0.06
3/4/2010Q4 2009$0.08+$0.08$0.08
10/28/2009Q3 2009$0.08+$0.08$0.08
7/29/2009Q2 2009$0.03$0.06+$0.03$0.06
4/28/2009Q1 2009($0.17)($0.04)+$0.13$0.04
3/3/2009Q4 2008$0.03+$0.03$0.04
10/29/2008Q3 2008($0.02)($0.01)+$0.01($0.01)
7/29/2008Q2 2008($0.04)($0.04)($0.02)
4/30/2008Q1 2008($0.07)($0.12)($0.05)($0.07)
3/4/2008Q4 2007($0.03)($0.05)($0.02)($0.02)
(Earnings results data provided by Zacks Investment Research)












LeMaitre Vascular (NASDAQ:LMAT) Earnings Frequently Asked Questions

When is LeMaitre Vascular's earnings date?

LeMaitre Vascular has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 24th, 2022 based off last year's report dates. Learn more on LMAT's earnings history

Did LeMaitre Vascular beat their earnings estimates last quarter?

In the previous quarter, LeMaitre Vascular (NASDAQ:LMAT) missed the analysts' consensus estimate of $0.33 by $0.03 with a reported earnings per share (EPS) of $0.30. Learn more on LMAT's earnings details

How can I listen to LeMaitre Vascular's earnings conference call?

The conference call for LeMaitre Vascular's latest earnings report can be listened to online. Listen to Conference Call

How can I read LeMaitre Vascular's conference call transcript?

The conference call transcript for LeMaitre Vascular's latest earnings report can be read online. Read Transcript

How much revenue does LeMaitre Vascular generate each year?

LeMaitre Vascular (NASDAQ:LMAT) has a recorded annual revenue of $129.37 million.

How much profit does LeMaitre Vascular generate each year?

LeMaitre Vascular (NASDAQ:LMAT) has a recorded net income of $21.22 million. LMAT has generated $1.32 earnings per share over the last four quarters.

What is LeMaitre Vascular's price-to-earnings ratio?

LeMaitre Vascular (NASDAQ:LMAT) has a trailing price-to-earnings ratio of 31.07 and a forward price-to-earnings ratio of 31.79. The price/earnings-to-growth ratio is 3.11.

What is LeMaitre Vascular's EPS forecast for next year?

LeMaitre Vascular's earnings are expected to grow from $1.29 per share to $1.44 per share in the next year, which is a 11.63% increase.

This page was last updated on 1/28/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.